Forty-eight subjects were enrolled in the study and 24 subjects (16 females, 8 males) were randomised to each of the 2.5 and 5mg groups (figure 1). There were no discontinuations during the study.
Additional Focus Groups Corroborate UltraShear Nano-THC Produces Equal to Much Better THC Experiences, Even from Lower THC Dosing Levels; Also, Lightning-Fast Pain Relief from Topical Use. SOUTH ...
ENA Respiratory Announces Dosing of First Participants in Phase II Study of INNA-051 Nasal Spray Designed to Protect Against Symptomatic Viral Respiratory Infections Melbourne, Australia, 29 January ...